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Objective:  Post-dural  puncture  headache  (PDPH)  is a common  complication  of  diagnostic  lumbar  punc-
tures.  Both  a non-cutting  needle  design  and  the use  of  smaller  size  needles  have  been  shown  to  greatly
reduce  the  risk  of  PDPH.  Nevertheless,  larger  cutting  needles  are  still widely  used.  This  study  describes
the  process  of  changing  the needle  in  an  outpatient  clinic  of  a Danish  neurology  department.
Methods:  Prospective  interventional  trial.  Phase  1:  22 G cutting  needle.  Phase  2: 25  G non-cutting  needle.
Practical  usability  of  each  needle  was  recorded  during  the  procedure,  while  the  rate  of PDPH  and  the
occurrence  of socioeconomic  complications  were  acquired  from  a standardized  questionnaire.
Results:  651  patients  scheduled  for diagnostic  lumbar  punctures  were  screened  for  participation  and  501
patients  were  included.  The  response  rate  was  80%  in  both  phases.
In phase  2,  signiﬁcant  reductions  were  observed  in  occurrence  of PDPH  (21  vs  50,  p  = 0.001),  number
of  days  spent  away  from  work  (55 vs  175,  p  < 0.001),  hospitalizations  (2 vs  17,  p < 0.001),  and number  of
bloodpatch  treatments  (2  vs  10,  p = 0.019).  Furthermore,  during  the  procedure,  both  the  need  for  multiple
attempts  (30%  vs  44%,  p  = 0.001),  and  the  failure-rate  of  the  ﬁrst  operator  (17%  vs  29%, p = 0.005)  were
reduced.
Conclusions:  Our study  showed  that smaller,  non-cutting  needles  reduce  the  incidence  of PDPH  and
are  easily  implemented  in an  outpatient  clinic.  Changing  the  needle  resulted  in fewer  socioeconomic
complications  and  fewer  overall  costs,  while  also  reducing  procedural  difﬁculty.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Diagnostic lumbar punctures are frequently implemented in the
outine evaluation of patients with neurological symptoms. Indica-
ions for the procedure are extensive ranging from suspicion of an
nﬂammatory or infectious disease to evaluation of chronic neu-
odegenerative disorders. Post-dural puncture headache (PDPH) is
 common complication of the test, with younger patients being
articularly at risk [1]. Although proven to reduce the occur-
ence of PDPH, the usage of small, non-cutting needles is still not
idespread in neurology departments [2]. In a UK survey, a cutting
eedle was used in over 70% of neurology units, and only two  of
8 units reported using a gauge smaller than 22 G [3]. In a US sur-
ey, the use of non-cutting needles was even lower, as only 2% of
he responding neurologists reported that they routinely used this
∗ Corresponding author. Tel.: +45 79 40 55 06; fax: +45 79 40 68 63.
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303-8467/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
type of needle [4]. The reasons given for the continued use of larger
cutting needles vary from economical and practical concerns to a
lack of up-to-date knowledge [2,4].
According to The International Classiﬁcation of Headaches
(ICHD-II), set out by the International Headache Society, PDPH is
a postural headache that arises within 5 days of a dural puncture.
The headache is aggravated within 15 min  of assuming an erect
posture, and improves within 15 min  of lying down. Furthermore,
at least one of ﬁve additional symptoms must be present. These
include neck stiffness, tinnitus, hypacusia, photophobia, and nau-
sea [5]. There may  also be severe complications following dural
puncture and PDPH. In a literature review, Zeidan et al. [6] dis-
covered 46 cases of unilateral or bilateral intracranial subdural
hematomas following spinal and epidural anesthesia, of which at
least six were mortal. Furthermore, spinal hematomas [7], post-
partum seizures [2], coma [8], and cranial nerve palsies [9] have
been attributed to dural puncture and PDPH. The incidence of PDPH
varies between <1% and 70%, and is dependent on both patient and
procedural characteristics [10]. Factors associated with increased
risk of PDPH include young age [11–13], low body-mass-index
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Study design.
BMI) [12,14], chronic headache or prior PDPH [11,12], female gen-
er [12], large needle diameter [15,16], and a cutting needle design
10,14–18], PDPH is most likely caused by persistent leakage from a
ural defect, which subsequently leads to intracranial hypotension
1]. As a consequence, reduced support of intracranial structures,
articularly during an erect position, leads to a downward pull
n pain-sensitive structures. This is substantiated by downward
isplacement of the posterior fossa content, observed in ortho-
tatic headache patients [19,20], and by the rare occurrence of
oth cranial nerve palsies and subdural hematomas following dural
uncture and PDPH [6,9]. Furthermore, intracranial cerebrospinal
uid (CSF) depletion possibly leads to compensatory vasodilation,
s predicted by the Monro-Kellie doctrine. Not unlike migraine, this
ould cause a substantial headache.
Owing to the apparent paradox between the evidence suppor-
ing the use of smaller, non-cutting needles, and the widespread
se of larger, cutting needles, we performed a prospective, inter-
entional trial to provide greater insight into the feasibility and
otential beneﬁts of using a 25 G non-cutting needle, as opposed
o the “classical” Quincke cutting 22 G needle, for diagnostic lum-
ar punctures. We  recorded the practical usability of the speciﬁc
eedle, the rate of PDPH, and the occurrence of socioeconomic
omplications.
. Methods
The study was approved by the Regional Ethics Committee.
e  obtained informed consent from all patients. The study took
lace at the outpatient clinic of the Department of Neurology, Vejle
ospital, Denmark (Fig. 1), and the study population consisted of
onsecutive patients older than 15 years undergoing scheduled or
ub-acute diagnostic lumbar puncture.
Patients evaluated for a novel onset and persisting headache
yndrome and/or refusing participation were not included
n = 150). We  designed the study as a two phase interventional trial,
n which we used the traumatic Spinocan 22 G needle in phase 1
nd the non-cutting Pencan 25 G needle in phase 2. Phase 1 ran
rom 1 March 2012 to 4 October 2012, with a sharp cross-over to
hase 2, which ended on 25 June 2013. Patients were blinded to
oth phase and needle type.
The ﬁrst year residents of the department performed the lum-
ar punctures, with the opportunity to call on an associate for
ssistance if necessary. If the department failed to perform thed Neurosurgery 130 (2015) 74–79 75
procedure, assistance from the anesthesiology department was
acquired. In both phases, the procedure was performed using
local anesthesia and the stylet was reinserted before the needle
was withdrawn. When using the traumatic needle the bevel was
arranged parallel to the spine. An introducer cannula was used
in phase 2. Data collected included patient demographics, BMI,
headache history, total number of puncture attempts, removed
spinal ﬂuid volume, and need for assistance. Following the proce-
dure, the patients were provided with a questionnaire that included
information on headache duration and severity, orthostatic compo-
nents, additional symptoms, inﬂuence on activities of daily living
and work, and, ﬁnally, if any treatment modalities had been used.
The questionnaire scored headache as either non-existent, mild or
severe. A nurse provided instructions and a stamped and addressed
envelope for returns. We  deﬁned PDPH as any orthostatic headache
accompanied by at least one additional symptom, according to the
ICHD-II classiﬁcation. If the patient experienced severe headache,
we likewise classiﬁed the PDPH as severe.
We  predeﬁned the primary outcome as the relative risk of PDPH
and severe PDPH depending on needle type, and calculated this
in a multivariate regression model reporting risk-ratios. We  cat-
egorized exposure variables according to clinical experience and
previously published studies, and included these in the model, if
univariate analysis showed an effect. We  compared baseline demo-
graphics and procedural characteristics between phases using a
Student’s t test for continuous variables, and Fisher’s exact test
for ratios. We evaluated the practical usability of each needle in
a multivariate model reporting risk-ratios of the need for asso-
ciate and anesthetic assistance. We  assessed the number of extra
attempts required per patient in a Poisson regression, adjusted for
needle type, age, gender, and BMI. We  compared number of days
spent either away from work or bedridden during each phase using
the Wilcoxon rank-sum test, and compared the need for various
treatment modalities using Fisher’s exact test. We  performed data
analysis using STATA version 11.0 statistical software.
3. Results
A total of 651 patients underwent lumbar puncture during the
study period. Of these, 501 met  the inclusion criteria and were
included in the study. A total of 96 patients were lost to follow-
up (19%); however, these were evenly distributed between phase
1 (N = 50) and phase 2 (N = 46). A total of 199 and 206 patients
completed the study in phases 1 and 2, respectively (Fig. 1). There
were no signiﬁcant differences between groups of patients in the
two phases regarding age, gender, BMI, history of headache, prior
PDPH, and CSF volume drawn (Table 1). Furthermore, adherence to
local anesthetics and stylet reinsertion was  even between phases. In
phase 1, a parallel cutting axis was used in 97% of lumbar punctures.
A total of 21 patients developed PDPH after lumbar puncture
with the non-cutting 25 G needle, vs 50 with the traumatic 22 G
needle (10% vs 25%) (Table 2). In a multivariate regression analy-
sis adjusting for age, gender, and BMI, this corresponded to a 50%
risk reduction when using the smaller, non-cutting needle (RR 0.50,
95% CI 0.32–0.76, p = 0.001). When only including severe PDPH in
the model, the risk-ratio decreased and remained statistically sig-
niﬁcant (RR 0.43, 95% CI 0.26–0.73, p = 0.002). The models further
showed that age under 50 years, female gender, and BMI  under 20
all signiﬁcantly increased the risk of both PDPH and severe PDPH
(Table 3). In univariate analyses, the risk of PDPH was not inﬂu-
enced by a history of chronic headache (RR 1.01, p = 0.856), previous
PDPH (RR 1.04, p = 0.477), or the need for multiple attempts during
the procedure (RR 1.06, p = 0.801).
After the procedure, a total of 175 days away from work was
reported for patients during phase 1, vs only 55 during phase 2
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Table  1
Demographic and procedural characteristics.
Characteristic Phase p Value
1: Cutting
“Spinocan” 22 G
n = 199
2: Non-cutting
“Pencan” 25 G
n  = 206
Age, years (SD) 47.8 (15.6) 50.5 (16.5) 0.09a
Female 64 62 0.68b
Male 36 38
Body  mass index, kg/m2 (SD) 25.8 (4.8) 25.9 (4.9) 0.80a
History of headache 18 22 0.51b
Prior PDPH 10 7 0.42b
CSF volume, mL (SD) 7.7 (1.3) 7.6 (1.4) 0.44a
Local anesthetics applied 98 100 0.36b
Parallel cutting axis (phase 1) 97 N/A N/A
Stylet  reinserted 96 92 0.14b
Values are percentages unless stated otherwise.
a Student’s t test.
b Fisher’s exact test.
Table 2
Primary and secondary outcome.
Measure Phase p Value
1: Cutting
“Spinocan” 22 G
n = 199
2: Non-cutting
“Pencan” 25 G
n  = 206
Primary outcome
PDPH 50 (25.1) 21 (10.2) 0.001a
Severe PDPH 40 (20.1) 15 (7.3) 0.002a
Secondary outcome
Procedural characteristics
More than one attempt 87 (43.7) 62 (30.1) 0.002b
Associate assistance 58 (29.1) 34 (16.5) 0.005a
Anesthesiologist assistance 12 (6.0) 8 (3.9) 0.22a
Follow up
Away from work, total numbers (total days) 40 (175) 17 (55) <0.001c
Bedridden, total numbers (total days) 57 (217) 32 (102) <0.001c
Any treatment 103 (51.8) 69 (33.5) <0.001d
Over the counter drugs 94 (47.2) 62 (30.1) 0.001d
Prescription drugs 28 (14.1) 17 (8.3) 0.08d
Hospitalization 17 (8.5) 2 (1.0) <0.001d
Bloodpatch 10 (5.0) 2 (1.0) 0.019d
Values are total numbers (%) unless stated otherwise.
a Multiple binary regression.
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c Wilcoxon rank-sum test (Mann–Whitney).
d Fisher’s exact test.
p < 0.001). Similarly, the total number of days spent bedridden was
ubstantially higher during phase 1 than during phase 2 (217 vs 102,
 < 0.001). The number of patients who needed hospitalization (17
s 2, p < 0.001) and bloodpatch (10 vs 2, p = 0.019) was also signiﬁ-
antly higher during phase 1 (Table 2). The median admission time
as found to be 1 day according to hospital records.
In multivariate regression models, the need for associate assis-
ance when using the non-cutting 25 G needle was  reduced by 42%
RR 0.58, p = 0.005), while no signiﬁcant difference in the need for
nesthesiologist assistance was observed. Furthermore, the need
or multiple attempts during the procedure was reduced from
4% to 30% (Table 2). This effect was signiﬁcant when registe-
ing the number of additional attempts in a Poisson regression
djusted for age, gender, and BMI  (Table 3). While age and gen-
er did not inﬂuence procedural success, a higher BMI  tended to
ncrease the need for associate assistance (RR 1.03, p = 0.078), and
igniﬁcantly increased the need for multiple attempts (IRR 1.04,
 < 0.001). To test for launching challenges during phase two, we
ompared the ﬁrst 50 patients with the subsequent 156 patients.
hough a slight early increase in the need for associate assistance
as observed, no signiﬁcant differences between procedural suc-
ess was observed (need for associate assistance, early 22% vs late15%, p = 0.27; more than one attempt needed, early 34% vs late 29%,
p = 0.60).
When using the unadjusted data, the numbers needed to treat
to avoid speciﬁc outcomes were: PDPH 7, severe PDPH 8, hospital-
ization 13, and bloodpatch application 25.
4. Discussion
Despite the overwhelming evidence in support of the use of
smaller, non-cutting needles for diagnostic lumbar punctures, the
use of larger cutting needles is still widespread in neurological
departments [3,4,21]. In our outpatient clinic, where a cutting 22 G
needle had previously been the needle of choice, we  performed
a prospective, interventional study, in order to test the feasibil-
ity, drawbacks, and potential beneﬁts of changing the needle to a
25 G non-cutting needle. While adjusting for potential confounders,
we were able to conﬁrm the ﬁndings of previous studies, namely,
that using a smaller, non-cutting needle signiﬁcantly reduces the
risk of PDPH [10,14–18]. Furthermore, after changing the needle,
a signiﬁcant reduction in both socioeconomic complications and
procedural difﬁculties was observed (Tables 2 and 3).
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Table  3
Regression models.
Binary regressions
Outcome Variables Risk-ratio 95% CI p Value
PDPH
Phase, non-cutting 25 G needle 0.50 0.32–0.76 0.001
Age,  <50 years 4.95 2.64–9.28 <0.001
Gender, female 2.58 1.39–4.82 0.003
BMI, <20 kg/m2 1.84 1.17–2.89 0.008
Severe PDPH
Phase, non-cutting 25 G needle 0.43 0.26–0.73 0.002
Age,  <50 years 6.60 2.94–14.86 <0.001
Gender, female 2.80 1.32–5.94 0.008
BMI, <20 kg/m2 2.17 1.31–3.60 0.003
Need  for associate assistance
Phase, non-cutting 25 G needle 0.58 0.40–0.85 0.005
Agea 1.00 0.99–1.01 0.816
Gender, female 1.03 0.71–1.51 0.870
BMIa 1.03 1.00–1.06 0.078
Poisson regression
Outcome Variables Incidence rate-ratio 95% CI p Value
Extra lumbar puncture attempts needed
Phase, non-cutting 25 G needle 0.69 0.55–0.87 0.001
Agea 1.00 0.99–1.01 0.890
Gender, female 0.94 0.74–1.19 0.610
BMIa 1.04 1.02–1.06 <0.001
a Continuous variable.
Table 4
Cost comparison between phases.
Phase 1 Phase 2
Cost of LP kits $8.84 × 199 = $1759 $19.09 × 206 = $3933
Hospital admission ($1209 per day) $1209 × 1 day × 17 = $20,553 $1209 × 1 day × 2 = $2418
Bloodpatch ($1500) $1500 × 10 = $15,000 $1500 × 2 = $3000
Total  costs $37,312 $9351
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ource: Expense rates reproduced from Dakka et al. [13].
Interestingly, the need for multiple attempts did not increase
he risk of PDPH in our study. This is consistent with the pathogen-
sis of the disease, such that only a successful attempt, penetrating
he dura, is capable of inducing PDPH. In addition, accounting for
he fact that in vitro investigation has conﬁrmed that both smaller
eedle size and a non-cutting design reduce CSF leakage, these
bservations seriously question the classic notion; that the risk of
DPH is somehow dependent on the skill or the experience of the
perator [18,22,23].
Our ﬁndings, that both young age and female gender are signif-
cant risk factors for PDPH, are in general agreement with those of
revious studies [11–13]. However, some discrepancy with regard
o the relationship between female gender and the risk of PDPH
xists in the literature [11]. Although 61 of 71 PDPH cases in our
tudy were female, women were also highly overrepresented in
atients younger than 50 years (157 vs 59). This underscores the
eed to assess the risk of PDPH in a multivariate design.
.1. Socioeconomic complications
To our knowledge, only two previous studies have esti-
ated the potential cost savings depending on choice of needle
or diagnostic lumbar punctures [13,24]. Both studies were of
etrospective design, with several limitations. However, simi-
ar results were achieved with regard to total healthcare costs
er lumbar puncture using the cutting needle (Dakka et al.,
239; Tung et al., $192). Both studies also showed a cost-
educing effect of using non-cutting needles. Using the suggested
osts of lumbar puncture kits, hospital admission, and blood-
atch application of Dakka et al., we showed similar costs per
umbar puncture with the 22 G cutting needle in our study;$45
$187. Since intravenous caffeine is not routinely administered
for treatment of PDPH at our department this expense was
omitted from the calculations. Of particular importance, we
observed a substantial cost reduction of $142, or 76%, per lum-
bar puncture after the switch to the 25 G non-cutting needle
(Table 4).
As also stated by both Dakka and Tung, these calculations do not
account for the loss of resources to the patients (loss of income)
or society (lost productivity) amongst other variables [13,24]. Our
ﬁndings that the total number of days spent away from work was
reduced from 175 to 55 after switching the needle suggest that this
contribution is substantial (Table 2).
4.2. Ease of use
Few studies have systematically reported the success rate of
diagnostic lumbar punctures dependent on needle type. Thomas
et al. [18] reported a slightly higher rate of multiple attempts or
failure to perform the procedure when using the atraumatic nee-
dle. However, this was not a signiﬁcant ﬁnding, but was consistent
with the subjective assessment that the operators found the non-
cutting needle more difﬁcult to use. Of particular interest, the use of
an introducer cannula was  left to the operator’s discretion in this
study, whereas in our study it was obligatory. We  speculate that
the use of a rigid introducer cannula with the non-cutting needle
helps guide the needle during the procedure, which could explain
the positive results of our study. Although we  report a similar fail-
ure rate of the primary operator to Thomas et al. when using the
non-cutting needle (both ∼16%, Table 2), this was achieved with a
much thinner needle (25 G vs 20 G). Similar to our results, Halpern
and Preston found a higher frequency of procedural difﬁculties
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Table  5
Advantages depending on needle choice.
Larger cutting needles Smaller non-cutting needles
1. Cheaper lumbar puncture kits. 1. Reduced incidence of PDPH.
2.  Routine – no change needed. 2. Considerable reduction of days spent away from work or bedridden.
3.  Better sensing of the dural resistance. 3. Considerable reduction in hospitalizations and bloodpatch applications.
4.  Local anesthetics not necessarily required. 4. Local anesthetics recommended. Calm patients leading to an easier procedure for both patients and operators.
5.  Faster collection time with thicker needles. 5. Higher success rate with fewer attempts.
6.  Potential reduction of the risk of rare, but dangerous complications including intracranial subdural hematoma.
7.  Overall cost saving.
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[ith cutting needles in a meta-analysis [16]. Importantly, when
ntroducing the 25 G non-cutting needle, no signiﬁcant launching
ifﬁculties were observed, and the overall success-rate was 96% in
ur department (Table 2).
Although use of smaller needles naturally extends the dura-
ion of the CSF sampling, this has limited clinical implications,
iven the small samples typically needed for diagnostic pur-
oses (3–12 mL). According to our regular personnel, this did not
nterfere with the patient ﬂow of the outpatient clinic. Further-
ore, needle design has not been shown to signiﬁcantly inﬂuence
pinal ﬂuid ﬂow rates, either in clinical or experimental settings
18,25].
. Limitations and conclusion
This study has some limitations; primarily, the non-randomized
esign should be noted. The signiﬁcance of this limitation is
educed by the prospective interventional design, the very sim-
lar demographics of each phase, and the multivariate approach
o the data-analysis. We  did not register indications for perform-
ng lumbar punctures; this limitation is, however, reduced by the
arge sample size and the comparable demographics of each phase.
lthough patients were blinded to both phase and needle type, this
as of course not possible for operators. Prior to the study initiation,
he traumatic needle was the needle of choice. Additionally, during
he study period new residents were continuously introduced as
art of the typical rotation of younger doctors at the department.
his limits potential experience bias achieved during phase two.
ince outcome measures were self-reported by questionnaire, we
hose a rather simple score for assessing the degree of headache in
rder to achieve as high a response rate and degree of accuracy as
ossible.
In conclusion, our results strongly support the use of a non-
utting, 25 G needle for diagnostic lumbar punctures and the study
hows that this needle can be easily implemented in the outpa-
ient unit of a Neurological department. When combined with an
ntroducer cannula and local anesthetics, the procedure was  eas-
er to perform and improved all predeﬁned outcomes, including
ate of PDPH and overall costs. This is fully in line with the rec-
mmendations of the American Academy of Neurology [21,26].
e have listed the advantages of the two types of needles in
able 5.
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